12 Health Care Stocks Moving In Friday's After-Market Session

Gainers

• MyMD Pharmaceuticals MYMD stock rose 11.9% to $2.25 during Friday's after-market session. The market value of their outstanding shares is at $88.8 million.
• Psychemedics PMD stock increased by 7.21% to $6.39. The market value of their outstanding shares is at $36.0 million.
• Renalytix RNLX stock moved upwards by 6.74% to $3.48. The market value of their outstanding shares is at $162.8 million.
• Predictive Oncology POAI stock moved upwards by 6.08% to $0.46. The company's market cap stands at $36.2 million.
• Infinity Pharmaceuticals INFI stock increased by 5.46% to $0.25. This security traded at a volume of 55.8K shares come close, making up 5.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $22.2 million.
• Citius Pharma CTXR stock moved upwards by 4.67% to $1.12. The market value of their outstanding shares is at $163.8 million.

Losers

• OncoSec Medical ONCS shares decreased by 13.9% to $1.89 during Friday's after-market session. Today's trading volume for this security ended up closing at 523.8K shares, which is 25.9 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $5.6 million.
• Cytek Biosciences CTKB stock fell 12.07% to $9.33. The company's market cap stands at $1.2 billion. As per the press release, Q4 earnings came out 3 days ago.
• Vaccinex VCNX shares fell 9.38% to $0.46. The company's market cap stands at $22.9 million.
• EUDA Health Holdings EUDA shares declined by 8.21% to $1.23. The company's market cap stands at $27.5 million.
• Cardio Diagnostics Hldgs CDIO stock decreased by 7.56% to $6.36. Trading volume for this security closed at 257.3K, accounting for 6.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $60.5 million.
• SenesTech SNES stock fell 6.48% to $1.95. The company's market cap stands at $1.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.